NORMIFLO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Normiflo, and what generic alternatives are available?
Normiflo is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in NORMIFLO is ardeparin sodium. Additional details are available on the ardeparin sodium profile page.
Summary for NORMIFLO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
DailyMed Link: | NORMIFLO at DailyMed |
US Patents and Regulatory Information for NORMIFLO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | NORMIFLO | ardeparin sodium | INJECTABLE;INJECTION | 020227-002 | May 23, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | NORMIFLO | ardeparin sodium | INJECTABLE;INJECTION | 020227-001 | May 23, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |